4//SEC Filing
ARIAD PHARMACEUTICALS INC 4
Accession 0001127602-15-022972
CIK 0000884731operating
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 5:08 PM ET
Size
8.3 KB
Accession
0001127602-15-022972
Insider Transaction Report
Form 4
Haluska Frank
VP, Clinical R&D, CMO
Transactions
- Exercise/Conversion
Performance stock unit
2015-07-15−8,000→ 0 total→ Common Stock (8,000 underlying) - Exercise/Conversion
Common Stock
2015-07-15+8,000→ 122,124 total - Sale
Common Stock
2015-07-16$8.54/sh−4,400$37,575→ 117,724 total
Footnotes (4)
- [F1]Shares were acquired upon vesting of performance stock units awarded on March 20, 2012.
- [F2]Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
- [F3]Each performance stock unit represents a right to receive one share of ARIAD common stock.
- [F4]The performance stock units vested on 7/15/15.
Documents
Issuer
ARIAD PHARMACEUTICALS INC
CIK 0000884731
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000884731
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 5:08 PM ET
- Size
- 8.3 KB